Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy.
Autor: | Martinović, Katarina Mirjačić, Vuletić, Ana, Miletić, Nevena Tišma, Matković, Suzana, Gavrilović, Dušica, Ninković, Aleksandra, Jurišić, Vladimir, Babović, Nada |
---|---|
Předmět: | |
Zdroj: | Journal of Clinical Pathology; May2024, Vol. 77 Issue 5, p343-351, 9p |
Databáze: | Complementary Index |
Externí odkaz: |